News
-
-
-
-
COMMUNIQUÉ DE PRESSE
Immunic, Inc. Announces Pricing of $5.1 Million Registered Direct Offering, Led by Aberdeen Investments
Immunic, Inc. announces pricing of $5.1 million registered direct offering led by Aberdeen Investments for clinical pipeline of therapies. Funds to be used for clinical trials and operations -
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Immunic to Participate in Scientific and Investor Conferences in March
Immunic to participate in scientific and investor conferences in March including the 34th Annual Meeting of the Society for Virology in Hamburg, Germany, and Leerink Partners Global Healthcare Conference in Miami